| Literature DB >> 19757150 |
Saskia E Luijnenburg1, Daniëlle Robbers-Visser, Adriaan Moelker, Hubert W Vliegen, Barbara J M Mulder, Willem A Helbing.
Abstract
Cardiovascular magnetic resonance (CMR) imaging provides highly accurate measurements of biventricular volumes and mass and is frequently used in the follow-up of patients with acquired and congenital heart disease (CHD). Data on reproducibility are limited in patients with CHD, while measurements should be reproducible, since CMR imaging has a main contribution to decision making and timing of (re)interventions. The aim of this study was to assess intra-observer and interobserver variability of biventricular function, volumes and mass in a heterogeneous group of patients with CHD using CMR imaging. Thirty-five patients with CHD (7-62 years) were included in this study. A short axis set was acquired using a steady-state free precession pulse sequence. Intra-observer and interobserver variability was assessed for left ventricular (LV) and right ventricular (RV) volumes, function and mass by calculating the coefficient of variability. Intra-observer variability was between 2.9 and 6.8% and interobserver variability was between 3.9 and 10.2%. Overall, variations were smallest for biventricular end-diastolic volume and highest for biventricular end-systolic volume. Intra-observer and interobserver variability of biventricular parameters assessed by CMR imaging is good for a heterogeneous group of patients with CHD. CMR imaging is an accurate and reproducible method and should allow adequate assessment of changes in ventricular size and global ventricular function.Entities:
Mesh:
Year: 2009 PMID: 19757150 PMCID: PMC2795153 DOI: 10.1007/s10554-009-9501-y
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Characteristics of the study population
| Characteristic | Value |
|---|---|
| Gender (male/female) | 26/9 |
| Age (years) | 22.2 ± 13.2 (6.8 – 61.6) |
| Heart rate (beats per minute) | 76 ± 11 (62 – 101) |
| Diagnosis |
|
| Aortic stenosis (repaired/unrepaired) |
(4/1) |
| ASD (unrepaired) |
|
| ccTGA, PA, VSD (repaired) |
|
| DORV, VSD, coarctation (repaired) |
|
| Fontan circulation (dominant RV/dominant LV) |
(3/7) |
| Intra-atrial correction of TGA |
|
| PA, VSD (repaired) |
|
| Pulmonary stenosis (repaired) |
|
| Tetralogy of Fallot (repaired) |
|
| VSD (unrepaired) |
|
Reported data are expressed as mean ± SD (range)
ASD atrial septal defect, ccTGA congenitally corrected transposition of the great arteries, PA pulmonary atresia, VSD ventricular septal defect, DORV double outlet right ventricle, RV right ventricle, LV left ventricle, TGA transposition of the great arteries
Intra-observer and interobserver variability analysis
| LV-EDV | LV-ESV | LV-SV | LV-EF | LV-mass | RV-EDV | RV-ESV | RV-SV | RV-EF | RV-mass | |
|---|---|---|---|---|---|---|---|---|---|---|
| Intra-observer | ||||||||||
| Mean difference ± SD | 1.6 ± 3.9 | 1.9 ± 3.4 | –0.4 ± 3.4 | –0.9 ± 2.3 | 0.6 ± 4.1 | 0.9 ± 5.3 | 3.4 ± 3.4 | –2.5 ± 4.4 | –1.6 ± 1.9 | 0.1 ± 4.7 |
| Limits of agreement | −6.3 to 9.4 | −4.9 to 8.8 | −7.2 to 6.5 | −5.6 to 3.7 | −7.6 to 8.9 | −9.7 to 11.5 | −3.3 to 10.2 | −11.4 to 6.4 | −5.4 to 2.1 | −9.3 to 9.5 |
| Mean value ± SD | 134.9 ± 42.5 | 50.3 ± 19.2 | 84.7 ± 27.8 | 62.9 ± 6.4 | 125.2 ± 47.3 | 179.3 ± 84.8 | 86.9 ± 51.9 | 92.3 ± 37.2 | 53.8 ± 9.5 | 81.8 ± 44.6 |
| Coefficient of variability (%) | 2.9 | 6.8 | 4.1 | 3.7 | 3.3 | 3.0 | 3.9 | 4.8 | 3.5 | 5.7 |
| Inter-observer | ||||||||||
| Mean difference ± SD | 0.3 ± 5.8 | 1.6 ± 5.1 | –1.1 ± 4.4 | –0.9 ± 2.5 | –0.3 ± 7.5 | 4.0 ± 7.1 | 6.8 ± 6.4 | –2.6 ± 5.2 | –2.7 ± 3.0 | 2.4 ± 5.0 |
| Limits of agreement | −11.2 to 11.9 | −8.6 to 11.8 | −9.9 to 7.6 | −5.9 to 4.1 | −15.3 to 14.8 | −10.2 to 18.1 | −6.1 to 19.6 | −13.0 to 7.8 | −8.7 to 3.4 | −7.5 to 12.4 |
| Mean value ± SD | 135.0 ± 41.6 | 49.7 ± 18.9 | 85.4 ± 28.0 | 63.5 ± 6.9 | 125.3 ± 47.6 | 177.6 ± 83.7 | 83.8 ± 50.9 | 93.9 ± 37.4 | 55.2 ± 9.8 | 80.6 ± 45.6 |
| Coefficient of variability (%) | 4.3 | 10.2 | 5.1 | 3.9 | 6.0 | 4.0 | 7.7 | 5.5 | 5.5 | 6.2 |
Reported data are expressed as mean ± SD. Coefficient of variability: expressed as a percentage of the SD of the difference divided by the mean of the two measurements. Volumetric variables in milliliters, mass variables in grams
LV left ventricle, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EF ejection fraction, RV right ventricle
Reports assessing intra-observer variability of biventricular parameters by SSFP CMR imaging
| Study | Population/diagnosis | M/F | Age (yrs) | Statistics | LV | RV | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EDV (%) | ESV (%) | SV (%) | EF (%) | Mass (%) | EDV (%) | ESV (%) | SV (%) | EF (%) | Mass (%) | |||||
| This study |
CHD | 26/9 | 22 ± 13 (7–62) | CoV
| 2.9 | 6.8 | 4.1 | 3.7 | 3.3 | 3.0 | 3.9 | 4.8 | 3.5 | 5.7 |
| Catalano [ |
Acquired/Healthy | 33/12 | 49 ± 20 (8–83) | CoV
| 7 | 9 | 10 | 12 | ||||||
| Clay [ |
Acquired/Healthy | 14/6 | 30 | CoV
| 5.2 | 6.5 | 2.9 | 4.7 | ||||||
| Hudsmith [ |
Healthy | 63/45 | 38 ± 12 (21–68) | CoV*
| 5.6 | 2.3 | 6.1 | 9.0 | 5.3 | |||||
| Maceira [ |
Healthy | 60/60 | (20–80) | CoV n = 10 | 3.6 | 6.5 | 5.9 | 4.0 | 5.7 | |||||
| Plein [ |
Acquired/Healthy | 23/18 | 53 (32–77) | CoV
| 2.8 | 10.1 | 3.4 | 5.2 | 3.9 | |||||
| Robbers-Visser [ |
Healthy | 30/30 | (8–17) | CoV
| 2.1 | 5.8 | 2.6 | 0.01 | 3.9 | 2.1 | 6.0 | 2.5 | 0.08 | 6.2 |
| Winter [ |
Systemic RV | 20/9 | 35 ± 12 | CoV
| 6.1 | 6.7 | 9.4 | 5.8 | ||||||
Reported data are expressed as mean ± SD (range). * CoV, indexed for body surface area (BSA)
CHD congenital heart disease, Acquired acquired heart disease, Healthy healthy controls, M male, F female, CoV coefficient of variability, LV left ventricle, RV right ventricle, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EF ejection fraction
Reports assessing interobserver variability of biventricular parameters by SSFP CMR imaging
| Study | Population/diagnosis | M/F | Age (yrs) | Statistics | LV | RV | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EDV (%) | ESV (%) | SV (%) | EF (%) | Mass (%) | EDV (%) | ESV (%) | SV (%) | EF (%) | Mass (%) | |||||
| This study |
CHD | 26/9 | 22 ± 13 (7–62) | CoV
| 4.3 | 10.2 | 5.1 | 3.9 | 6.0 | 4.0 | 7.7 | 5.5 | 5.5 | 6.2 |
| Catalano [ |
Acquired/Healthy | 33/12 | 49 ± 20 (8–83) | CoV
| 8 | 11 | 12 | 13 | ||||||
| Clay [ |
Acquired/Healthy | 14/6 | 30 | CoV
| 3.3 | 6.8 | 4.6 | 3.7 | ||||||
| Hudsmith [ |
Healthy | 63/45 | 38 ± 12 (21–68) | CoV*
| 2.7 | 3.3 | 5.2 | 9.6 | 10.7 | |||||
| Karamitsos [ |
Healthy | 5/5 | 34 ± 14 | CoV
| 2.6 | 6.9 | 3.4 | 2.9 | 5.8 | |||||
| Maceira [ |
Healthy | 60/60 | (20–80) | CoV
| 6.3 | 8.6 | 7.0 | 4.4 | 7.8 | |||||
| Mooij [ |
ASD/TOF/Healthy | 34/26 | 21 ± 13 | CoV*
| 3.6 | 10.5 | 6.6 | 5.8 | 5.3 | 6.4 | 13.0 | 11.8 | 8.0 | 11.3 |
| Plein [ |
Acquired/Healthy | 23/18 | 53 (32–77) | CoV
| 4.3 | 9.4 | 9.5 | 6.0 | 6.0 | |||||
| Robbers-Visser [ |
Healthy | 30/30 | (8–17) | CoV
| 5.3 | 13.9 | 3.3 | 2.3 | 6.1 | 3.4 | 7.6 | 4.5 | 2.0 | 8.9 |
| Winter [ |
Systemic RV | 20/9 | 35 ± 12 | CoV
| 10.0 | 12.7 | 12.2 | 7.5 | ||||||
Reported data are expressed as mean ± SD (range). * CoV, indexed for BSA
ASD atrial septal defect, TOF tetralogy of Fallot. Other abbreviations as in Table 3